Kleiner Perkins-backed Ambiq pops on IPO debut

Ambiq Micro, a 15-year-old producer of energy-efficient chips for wearable and medical gadgets, closed its first day of buying and selling on Wednesday at $38.53 a share, a 61% enhance from the $24 IPO value the corporate set the day past.

The success of the IPO alerts robust investor demand within the public marketplace for new small-cap corporations benefiting from AI innovation.

Ambiq closed its first day as a public firm with a valuation of $656 million (excluding worker choices). This represents a big enhance from its final non-public funding valuation of $450 million in 2023, based on PitchBook.

Ambiq has pitched itself as well-positioned to capitalize on the expansion pushed by AI. “As a result of we’re so low vitality, we are able to put extra intelligence and extra AI on board” of edge processors, the corporate’s CTO Scott Hanson informed TechCrunch.

For the three months that ended March 31, Ambiq posted a web lack of $8.3 million towards revenues of $15.7 million, the corporate’s S1 filing shows. The Q1 outcomes mark a slight enchancment from the primary quarter of 2024, when the corporate reported a $9.8 million loss on $15.2 million in income.

Kleiner Perkins and EDB Investments, a Singaporean state-backed entity, are the most important outdoors backers of Ambiq, based on the submitting.

Wen Hsieh, who was a normal companion at Kleiner Perkins till 2023, first backed Ambiq when the corporate raised its Sequence C in 2014. Hsieh additionally invested in Ambiq after he launched his personal enterprise agency, Matter Venture Partners, two years in the past.